Gabriela Kořínková

Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment

Lenka Oplustilova, Kamila Wolanin, Martin Mistrík et al. · Cell Cycle · 2012 · 161 citations · Full text

Cancer Cell Sensitivity, Parp Activity, Pathology +19

Synthesis of A-Seco Derivatives of Betulinic Acid with Cytotoxic Activity

Milan Urban, Jan Šarek, Jiří Klinot et al. · Journal of Natural Products · 2004 · 128 citations

New Lupane Derived Compounds with Pro-Apoptotic Activity in Cancer Cells:  Synthesis and Structure−Activity Relationships

Jan Šarek, Jiří Klinot, Petr Džubák et al. · Journal of Medicinal Chemistry · 2003 · 87 citations

In vitro chemoresistance profile and expression/function of MDR associated proteins in resistant cell lines derived from CCRF-CEM, K562, A549 and MDA MB 231 parental cells.

V. Noskova, Petr Džubák, G Kuzmina et al. · PubMed · 2002 · 54 citations

Chemoprevention Strategy, Vitro Chemoresistance Profile, Molecular Biology +19

Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine

Hana Kovářová, Marián Hajdúch, Gabriela Kořínková et al. · Electrophoresis · 2000 · 50 citations